FDA Approved: XOPENEX HFA — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for XOPENEX HFA (levalbuterol tartrate). The approval relates to changes described in the supplemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• XOPENEX HFA (Levalbuterol tartrate)

Snippet

SUPPL AP for XOPENEX HFA (LEVALBUTEROL TARTRATE)